Abstract:Background: Dysregulation of signal transducers and activators of transcription (STATs) is associated with many cancers, but no role of STAT1 in human tumor progression has been demonstrated. Methods: We compared STAT1 protein expression in squamous cell carcinoma of the head and neck (SCCHN) tumors (n = 28) and normal oropharyngeal mucosa samples (n = 10) from patients without cancer as assessed by immunoblotting. Stable clones were established from SCCHN 1483 cells that were transfected with a STAT1 expression construct; cell growth and cisplatin-induced apoptosis of the clones and vector control-transfected 1483 cells were compared using trypan blue exclusion and Annexin V staining and expression of the cyclin-dependent kinase inhibitor p21 was assayed by immunoblotting. The growth of STAT1-overexpressing SCCHN 1483 xenograft tumors was compared with that of xenograft tumors derived from cells transfected with vector control DNA. DNA from SCCHN tumors (n = 16) and paired peripheral blood lymphocytes were analyzed for STAT1 mutations and promoter methylation using methylation-specific polymerase chain reaction and bisulfite sequencing. SCCHN cell lines (PCI-15b, 1483, and UM-2213) were treated with the demethylating agent azacytidine alone or in combination with the cytotoxic drug cisplatin, and expression of STAT1 and p21 were monitored by immunoblotting. All statistical tests were two-sided. Results: STAT1 levels were statistically significantly lower in the SCCHN tumors than normal mucosa (median = 0.8 relative units versus 2.4, difference = 1.6, 95% confidence interval [CI] = 1.3 to 2.0, P <.001). Overexpression of STAT1 abrogated the growth of SCCHN cells and xenograft tumors and increased p21 expression. STAT1 expression levels of the tumors with STAT1A promoter methylation (n = 12) were lower than those of tumors (n = 4) without promoter methylation of STAT1 (P = .008). Azacytidine treatment increased expression of STAT1 and p21 in SCCHN cell lines and increased apoptosis in cisplatin-treated 1483 cells compared with cisplatin treatment alone (mean = 61.3% versus 25.8%, difference = 35.5%, 95% CI = 24.5% to 43.4%; P =.028). Conclusion: STAT1 can function as a tumor suppressor in SCCHN cells. Silencing of the STAT1 gene via promoter methylation may contribute to SCCHN tumor cell growth.

Gene Methylation Inhibits the Expression of Squamous Cell Carcinoma Antigen 1 in Nasopharyngeal Carcinoma Tissues

Pharmacologic demethylation identifies UCHL1 as a tumor suppressor gene frequently silenced in nasopharyngeal and multiple other carcinomas

Hypermethylation Leads to Down-regulated 14-3-3 Sigma Expression in Nasopharyngeal Carcinoma Tissues*

Methylation of annexin A1 Gene Promotes Lymphoid Node Metastasis in Nasopharyngeal Carcinoma

Methylated Tumor Suppressor Gene SCARA5 Inhibits the Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma.

The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas

TMEM130 Regulates Cell Migration Through DNA Methylation in Nasopharyngeal Carcinoma.

Clinical significance of hMLH1 gene methylation and protein expression in nasopharyngeal carcinoma

Inactivation Of 14-3-3 Sigma By Promoter Methylation Correlates With Metastasis In Nasopharyngeal Carcinoma

DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma

Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis

Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability.

Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism

Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas

Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma

Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.

Frequent Epigenetic Inactivation of Myocardin in Human Nasopharyngeal Carcinoma.

Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.

Down-Regulation Of Prostate Stem Cell Antigen (Psca) By Slug Promotes Metastasis In Nasopharyngeal Carcinoma